William E. Fahl

Also affiliated with Wisconsin Institutes for Discovery, Madison Group (United States), Edison Pharmaceuticals (United States), Mycovia Pharmaceuticals (United States)

Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Suppression of Inflammation-Associated Kidney Damage Post-Transplant Using the New PrC-210 Free Radical Scavenger in Rats”.

Suppression of Inflammation-Associated Kidney Damage Post-Transplant Using the New PrC-210 Free Radical Scavenger in Rats

Biomolecules(2021)10.3390/biom11071054

N/A

0DataRank · unranked

8 citations

Nancy A. Wilson, Weifeng Zeng, Bret Verhoven, Weixiong Zhong, Maya M. Gitter +2 more

Determination of plasma levels of the active thiol form of the direct-acting PrC-210 ROS-scavenger using a fluorescence-based assay

Analytical Biochemistry(2021)10.1016/j.ab.2021.114100

N/A

0DataRank · unranked

3 citations

William E. Fahl, Emma Dreischmeier